0001074871 1 2026-07-15 2026-07-15 0001074871 2 2026-07-15 2026-07-15 0001074871 3 2026-07-15 2026-07-15 0001074871 2026-07-15 2026-07-15 iso4217:USD pure shares S-3 EX-FILING FEES 0001074871 N/A N/A S-3 Modular Medical, Inc. false Equity Common Stock, par value $0.001 per share issuable upon exercise of the Warrants true 108372 2.2750 246546.30 0.0001381 34.05 false Equity Common Stock, par value $0.001 per share issuable upon exercise of the Underwriter Warrants true 32655 2.2750 74290.13 0.0001381 10.26 false Equity Common Stock, par value $0.001 per share true 52000 2.2750 118300.00 0.0001381 16.34 439136.43 60.65 0.00 0.00 60.65 The shares of common stock of Modular Medical, Inc. (the “Registrant”) will be offered for resale by the selling stockholders pursuant to the prospectus contained herein. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement also covers any additional number of shares of common stock issuable upon stock splits, stock dividends, or other distribution, recapitalization or similar events with respect to the shares of common stock being registered pursuant to this registration statement.<br/><br/>This registration statement registers the resale by the selling stockholders of up to an aggregate of 193,037 shares of the Registrant’s common stock, par value $0.001 per share, consisting of (a) 108,412 shares of common stock issuable upon the exercise of warrants to purchase shares of common stock, pursuant to Warrant Inducement Letter Agreements, dated September 22, 2025; (b) 32,655 shares of common stock issuable upon the exercise of underwriter’s warrants to purchase shares of common stock, pursuant to the Underwriting Agreement, dated December 10, 2025; and (c) 52,000 shares of common stock issued to two service provides to the Registrant.<br/><br/>Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(c) of the Securities Act, based upon the average of the high and low prices for a share of common stock as reported on the Nasdaq Capital Market on August 3, 2026, which date is a date within five business days of the filing of the registration statement for the registration of the securities listed in the table above. The shares of common stock of Modular Medical, Inc. (the “Registrant”) will be offered for resale by the selling stockholders pursuant to the prospectus contained herein. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement also covers any additional number of shares of common stock issuable upon stock splits, stock dividends, or other distribution, recapitalization or similar events with respect to the shares of common stock being registered pursuant to this registration statement.<br/><br/>This registration statement registers the resale by the selling stockholders of up to an aggregate of 193,037 shares of the Registrant’s common stock, par value $0.001 per share, consisting of (a) 108,412 shares of common stock issuable upon the exercise of warrants to purchase shares of common stock, pursuant to Warrant Inducement Letter Agreements, dated September 22, 2025; (b) 32,655 shares of common stock issuable upon the exercise of underwriter’s warrants to purchase shares of common stock, pursuant to the Underwriting Agreement, dated December 10, 2025; and (c) 52,000 shares of common stock issued to two service provides to the Registrant.<br/><br/>Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(c) of the Securities Act, based upon the average of the high and low prices for a share of common stock as reported on the Nasdaq Capital Market on August 3, 2026, which date is a date within five business days of the filing of the registration statement for the registration of the securities listed in the table above. The shares of common stock of Modular Medical, Inc. (the “Registrant”) will be offered for resale by the selling stockholders pursuant to the prospectus contained herein. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement also covers any additional number of shares of common stock issuable upon stock splits, stock dividends, or other distribution, recapitalization or similar events with respect to the shares of common stock being registered pursuant to this registration statement.<br/><br/>This registration statement registers the resale by the selling stockholders of up to an aggregate of 193,037 shares of the Registrant’s common stock, par value $0.001 per share, consisting of (a) 108,412 shares of common stock issuable upon the exercise of warrants to purchase shares of common stock, pursuant to Warrant Inducement Letter Agreements, dated September 22, 2025; (b) 32,655 shares of common stock issuable upon the exercise of underwriter’s warrants to purchase shares of common stock, pursuant to the Underwriting Agreement, dated December 10, 2025; and (c) 52,000 shares of common stock issued to two service provides to the Registrant.<br/><br/>Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(c) of the Securities Act, based upon the average of the high and low prices for a share of common stock as reported on the Nasdaq Capital Market on August 3, 2026, which date is a date within five business days of the filing of the registration statement for the registration of the securities listed in the table above.